Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Aconitate decarboxylase 1 regulates glucose homeostasis and obesity in mice

Frieler RA., Vigil TM., Song J., Leung C., Goldstein DR., Lumeng CN.

Animal Study on Type 2 Diabetes, Chronic Inflammation, published in Obesity (Silver Spring) (2022) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Obesity (Silver Spring) (2022)
Reported sample size
—
Source database
Europe PMC
PMID
35927796
PMCID
PMC9541899
DOI
10.1002/oby.23509
Citations
23

Abstract (original English)

Objective The intersection between immunology and metabolism contributes to the pathogenesis of obesity-associated metabolic diseases as well as molecular control of inflammatory responses. The metabolite itaconate and the cell-permeable derivatives have robust anti-inflammatory effects; therefore, it is hypothesized that cis-aconitate decarboxylase (Acod1)-produced itaconate has a protective, anti-inflammatory effect during diet-induced obesity and metabolic disease. Methods Wild-type and Acod1 -/- mice were subjected to diet-induced obesity. Glucose metabolism was analyzed by glucose tolerance tests, insulin tolerance tests, and indirect calorimetry. Gene expression and transcriptome analysis was performed using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and RNA sequencing. Results Wild-type and Acod1 -/- mice on high-fat diet had equivalent weight gain, but Acod1 -/- mice had impaired glucose metabolism. Insulin tolerance tests and glucose tolerance tests after 12 weeks on high-fat diet revealed significantly higher blood glucose levels in Acod1 -/- mice. This was associated with significant enrichment of inflammatory gene sets and a reduction in genes related to adipogenesis and fatty acid metabolism. Analysis of naive Acod1 -/- mice showed a significant increase in fat deposition at 3 and 6 months of age and obesity and insulin resistance by 12

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMice, Inbred C57BLMiceInsulin ResistanceObesityInsulinCarboxy-LyasesGlucoseAnti-Inflammatory AgentsHomeostasis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research